Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Justin Goldfarb specializes in medical oncology, internal medicine, and hematology.
Growing up in suburban Detroit, Dr. Goldfarb followed his true passion to become a hematologist and medical oncologist. A published author on topics including lymphoma and breast cancer, he is double board-certified in medical oncology and internal medicine, and fellowship-trained in hematologic disorders and solid tumors.
Dr. Goldfarb earned a bachelor’s degree from the University of Colorado at Boulder and holds a medical degree from Midwestern University in Chicago. He completed an internal medicine residency at Rush University Medical Center in Chicago, followed by a medical oncology fellowship at Baylor University Medical Center in Dallas. With academic appointments at Pritzker School of Medicine at the University of Chicago and Midwestern University, Dr. Goldfarb thoroughly enjoys teaching and mentoring medical students.
"The care I receive from Dr. Goldfarb is exceptional. He listens attentively to my concerns and he provided me with a treatment plan that yields positive results. The entire team at the clinic display a high level of professionalism and make me feel comfortable while I'm there . Nicole Lee is exceptional as well." -Christian
"Dr Goldfarb has been helping me fight lung cancer for two years and is a very caring person." -JC
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Mohammad Nasser, MD, founder of Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona, is a board-certified internal medicine physician and population health specialist. Dr. Nasser has a special interest in complex patient care, gaining extensive experience as a hospitalist and internist providing care in hospitals, long-term acute care centers, and subacute rehabilitation.
With a well-known reputation as an exceptional health care innovator, Dr. Nasser creates and implements programs that improve the quality of care and diminish costs for hospitals and skilled nursing facilities.
Born and raised in Michigan, Dr. Nasser received his bachelor’s degree from Wayne State University in Detroit Michigan. After receiving his medical degree at the American University of the Caribbean School of Medicine in Sint Maarten, he completed his internship and internal medicine residency at Ascension Providence Hospital, Michigan State University College of Human Medicine in Grand Rapids, Michigan.
Dr. Nasser is known for numerous accomplishments in his field. He was the medical director at Arkos Health and managed more than 200,000 patients through his transitional care management program.
During his tenure at Arkos Health, Dr. Nasser developed an inpatient program that shortened hospital stays and mobilized patients to the next level of care. He also implemented a skilled nursing program that improved the post-discharge process.
As a respected author, Dr. Nasser published articles in medical journals as well as the well-known book, “Management of Chronic Kidney Disease.” He also served as a manuscript reviewer for medical journals, including the Journal of the American College of Cardiology.
Dr. Nasser is a proud member of the Phoenix community, where he welcomes patients and is highly regarded for his quality of care and leadership roles.
Board-certified internal medicine physician, William Nassour, MD, provides integrative health care at Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona. His expertise includes all aspects of adult health care, however, he has a special interest in cardiovascular disease, diabetes, geriatrics, and post-acute care.
Dr. Nassour is well-respected for go-to advice, with peers seeking his assistance and guidance in geriatrics and post-acute care, and patients depending on his understanding to provide honest evaluations and recommend individualized care.
Dr. Nassour received his medical degree from Tishreen University in Latakia, Syria, and completed his residency training in internal medicine at the New York University Langone Health in Brooklyn, New York.
With more than a decade of experience as a practicing physician in hospital medicine, including outpatient and subacute care, Dr. Nassour has developed extensive knowledge and skills that help him better understand each patient and create effective treatment plans.
He has successfully filled leadership roles as the medical director in different medical settings. He also remains active on various hospital committees.
Dr. Nassour welcomes new and current patients at Leading MDs, where he collaborates with each person to improve their health and well-being.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Daniel Skinner, MD, is board-certified in dermatology and Mohs micrographic surgery. He provides expert care at Skin Cancer Specialists, located in Mesa, Arizona.
Dr. Skinner is a 5th-generation Arizonan who grew up in Mesa and graduated from Mountain View High School. He went on to attend Brigham Young University in Provo, Utah, where he graduated with a degree in business management. He then attended the University of Arizona College of Medicine in Tucson, where he developed an interest in dermatologic surgery.
During medical school, he was a leader and volunteer in many different medical school organizations. He completed a one-year internship in internal medicine at Banner Good Samaritan Medical Center in Phoenix, Arizona, and a three-year dermatology residency at the University of Missouri in Columbia, where he served as chief resident in his final year. He has presented research at many local and national meetings and has published research on the use of Mohs surgery for rare skin cancer, as well as a book chapter on dermabrasion.
Dr. Skinner concluded his training with an intensive one-year fellowship in Mohs micrographic and dermatologic surgery in Birmingham, Alabama, with Dr. Christopher Harmon, one of the nation's leading Mohs surgeons. Dr. Skinner has performed over 10,000 skin cancer surgeries. In addition to training in Mohs surgery and skin cancer removal, he has expertise in facial reconstruction after skin cancer removal.
Dr. Skinner is currently the president of the Phoenix Dermatology Society and on the board of directors of the Arizona Dermatology and Dermatologic Surgery Society. In addition, he is very active in volunteer work for his church and enjoys spending time playing and watching sports.
When he is not at work, Dr. Skinner enjoys spending time with his wife, Marie, and their six children.
Mohs Micrographic and Dermatologic Surgery - Surgical Dermatology Group - Birmingham, AL Fellowship
University of Missouri - Columbia, MO Residency - Dermatology
University of Arizona - Tucson, AZ Medical School
Brigham Young University - Provo, UT BS Business Management
Certifications/Memberships:
American College of Mohs Surgery - Fellow
American Academy of Dermatology - Fellow
American Medical Association - Member
Arizona Medical Association - Member
Arizona Dermatology and Dermatologic Surgery Society - Member
Phoenix Dermatology Society - Member
American Board of Dermatology - Board Certified
Awards/Recognition:
Dr. Skinner has consistently been recognized by his patients and peers for his excellence in dermatology and patient care. He has received the Patients' Choice Award, the Compassionate Doctor Recognition, and the On-time Award by the website, vitals.com, which is rated and awarded by patients. The vitals.com website states the following: "This award recognizes doctors who make a difference in the lives of their patients. This honor is given to those physicians who have received near perfect scores as voted by their patients." In addition, Dr. Skinner was elected by his peers to be the President of the Phoenix Dermatology Society, a group of over 150 dermatologists in the Phoenix metropolitan area.
“This is my second trip to see Dr, Skinner and again I was most impressed. When I found out I needed another MOHS treatment, I was at ease knowing Dr. Skinner would be performing the procedure. Most efficient, as is his whole staff from the front office to the other half of the office (putting you back together). You know what you get here ---- THE BEST IN THE BUSSINES!”
Dr. Daniel Skinner, MD
Dermatologist
2250 W. Southern Ave.
Suite 102
Mesa, AZ 85202
4.98(95)
Dr. Sanjeev Gopal, MD
Hematology & Oncology Physician 36.6 mi
Dr. Sanjeev Gopal is a board-certified specialist in medical oncology and hematology with Arizona Center for Cancer Care and Virginia G. Piper Cancer Care Network.
With offices in Apache Junction, Mesa and Gilbert, Dr. Gopal is committed to providing the highest level of care with a priority of treating each patient and their families with utmost respect. It is important to Dr. Gopal to not only prolong lives of his patients, but to improve the quality of their lives.
"Dr Gopal is fabulous! He is really focused on you and what you are going through! Compassionate and knowledgeable!" -Pat
"Dr. Gopal and his staff are without a doubt the EXCEPTION TO TODAY'S IMPRESSION OF MEDICAL PROVIDERS! Dr. Gopal obviously took the time to hire his staff, because they are just as compassionate, caring, kind and loving as him. Trust me, I am qualified to make these statements; not my first rodeo, ya'll. I don't typically take the time for reviews, but for Dr. Gopal, I absolutely will make an exception as he deserves all the recognition for who he simply is, as a person (I think). Dr. Gopal took a personal interest in my care from the moment I was referred to him. "Bedside manner?" Dr. Gopal treated me like a "person" he cares for, like family. Therefore, that term is not relevant. If you ask me, that is a good thing!...' -Heidi
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Joan Dahmer specializes in hematology, medical oncology, and internal medicine.
Dr. Dahmer joined Arizona Center for Cancer Care in 2008 when her team at Arizona Center for Hematology and Oncology partnered with the practice. Prior to joining Arizona Center for Hematology and Oncology in 2002, Dr. Dahmer developed the oncology program at both Maryvale and Memorial Hospitals in Phoenix. She was also Chief of Medicine at Laurentian Hospital in California and has served as a medical consultant for prominent centers and labs.
Dr. Dahmer has been active in the medical community as a past or current member of several organizations, most recently as a member of The Arizona Clinical Oncology Society, the American Society of Hematology, and the Association of Community Cancer Centers, to name a few.
She has also volunteered her time to many health-related causes, including serving as medical director for the HAVEN Program of Northeastern Ohio, a comprehensive program for those infected with and affected by HIV.
She has presented on a number of topics including, medical marijuana, cardiac assessment in home care to home health nurses, women in medicine, oral & lung cancer and medicine as a career.
"Dr. Dahmer is very good, kind, understanding, and very professional 👏." -Cozetta
"Virginia Piper cancer center has the nicest. Most accommodating staff and nurses. Doc Dahmer is the best doctor I have heard of. She is patient. Kind. Incredibly smart. Very thorough. I just love her. You wont be disappointed with her." -Samantha
Dr. Andrew J. Buresh specializes in medical oncology, hematology, and internal medicine. He is interested in all aspects of clinical oncology and hematology, with a particular interest in gastrointestinal, breast, lung, and prostate cancer, as well as myelodysplasia, coagulation disorders, lymphoma, and myeloma.
Dr. Buresh joined Arizona Center for Cancer Care in 2013 when Desert Springs Cancer Care Center, which he founded and partnered with the practice. He is a member of the American Society of Clinical Oncology, American Society of Hematology and Arizona State Physicians Association.
Dr. Buresh is a multi-year “Top Doc” honoree by Phoenix Magazine and was chosen for the cover of the annual ranking magazine in 2013. He was also honored by the Phoenix Business Journal as among its “40 Top Business Leaders under Age 40.”
Dr. Buresh and his wife are blessed to be the proud parents of three beautiful children. When not caring for patients, Dr. Buresh enjoys spending his time with family, exercising, reading, playing basketball, golf, guitar, and coaching youth sports. He also speaks basic medical Spanish.
"Warm and caring in all aspects of care. He’s special in his approach and looks at the big picture. Spends a lot of time asking questions and is conservative in his approach. So glad I was referred to him and will continue to refer him to others. Don’t be afraid~ take him on your journey with you!" -Robin
Dr. Jason Samuelian is a Board-certified Radiation Oncologist, with expertise in novel radiation techniques including Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Radiosurgery (SRS), and Stereotactic Ablative Radiotherapy (SABR). He has a particular interest in using new and advanced treatment techniques to minimize side effects. He derives great satisfaction from spending time with his patients and developing relationships with them that last long beyond their cancer care.
Dr. Samuelian joined Arizona Center for Cancer Care in 2015. He earned his Bachelor of Science degree in Exercise Physiology from Brigham Young University, where he graduated cum laude. He earned his medical doctorate at Midwestern University in Glendale, where he was awarded the MICA Scholastic Award in 2008, and graduated with Honors in 2010. He completed an internal medicine internship at Banner Good Samaritan Medical Center, followed by residency training at the Baylor College of Medicine, where he also served as chief resident. In addition, Dr. Samuelian has completed two brachytherapy fellowships — at the MD Anderson Cancer Center and the Seattle Prostate Institute.
Dr. Samuelian is a member of the American Society of Therapeutic Radiation Oncology, American Brachytherapy Society, American College of Radiology, American College of Radiation Oncology, and the American Society of Clinical Oncology. He has been invited to serve on the ASCO Professional Development Committee. He currently serves as Chairman of the Cancer Committee at Banner Boswell Medical Center in Sun City, a program accredited by the Commission on Cancer (CoC).
Dr. Samuelian actively participates in cooperative group clinical trials. His research has been published in peer-reviewed medical journals, and he has presented at national meetings on SABR for COPD patients with early-stage lung cancer, IMRT for the treatment of rectal cancer, and prostate cancer brachytherapy, among others.
"Dr. Samuelian has always been very honest and truthful in presenting us with our options I trust his opinion 100 present and would highly recommend him to anyone seeking his treatment." -Rick
"I have been very impressed with Dr. Jason Samuelian. He seems extremely knowledgeable. I have had several doctors that had horrible bedside manner. Dr. Samuelian has an incredible bedside manner. It was so obvious that he was really concerned with my welfare. I would also like to do a shout out to his support team. They were incredible, and kind. I can't say enough about the entire experience. I'd give him six stars if I could." -Peter
Dr. Cory Heal is a radiation oncologist who has expertise in a full breadth of radiation oncology treatments for both malignant and benign diseases in children and adults.
Before joining Arizona Center for Cancer Care, Dr. Heal received a Bachelor of Science from Brigham Young University and his Medical Doctorate from Drexel University. He then completed an internship in Internal Medicine at Abington Memorial Hospital and a residency in radiation oncology at the University of Arizona, where he served as Chief Resident.
Dr. Heal specializes in the treatment of malignancies of the breast, prostate, lung, skin, head and neck, gynecological tract, gastrointestinal tract, central nervous system, hematologic/lymphatic systems, and musculoskeletal systems. He also treats a wide array of benign diseases that benefit from radiation. Dr. Heal utilizes the latest treatment techniques in his practice, including Stereotactic Radiosurgery (SRS), Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), PLUVICTO, LUTATHERA, and Stereotactic Ablative Radiotherapy (SABR/SBRT). Dr. Heal has additional specialized training and research interests in the use of HDR brachytherapy for several anatomic sites. His other research interests include patient safety and quality improvement.
An Arizona native who grew up in the East Valley, Dr. Heal feels privileged to serve the community he loves. He always seeks to be an advocate for his patients as he guides them through treatment. He enjoys the lasting relationships he develops with his patients and their families and feels honored to take part in their care.
Dr. Heal and his wife, Emily, have four children. Outside of medicine, Dr. Heal loves spending his free time being a dad, cooking new foods in the kitchen, and making memories with his family outdoors.
"Dr. Heal and his team were so thorough and thoughtful with explanations which reduced my anxiety and made daily radiation appointments very easy to manage!" -Wendy
"Couldn't be more satisfied with Dr. Heal. He's a wonderful person both personally and professionally, making sure to explain every aspect of the treatment for my brain cancer, as well as being an all-around good guy! I'm a lucky man." - Daniel
Dr. Parmjeet Kumar Banghar specializes in hematology, medical oncology, and internal medicine. He joined Arizona Center for Cancer Care in 2008 when his team at Arizona Center for Hematology and Oncology partnered with the practice.
Currently, Dr. Banghar is a member of the American Society of Clinical Oncology and American Society of Hematology. He has participated in a research study involving cerebrovascular diseases and been published in several journals, including Leukemia Research and the Indian Journal of Medical Sciences. He has also presented on a number of topics, including sonographic evaluation of the spleen in sickle cell syndromes, lennox gastaut syndrome and sweet syndrome in a patient with acute myeloid leukemia.
"This doctor is smart and knows cancer. The staff is the best. My nurses who give me shots are the best! Highly reccomend this office." -Lina
"I have been Dr. Banghar's patient since 2019 and just found out I could give him a review. Wish I had been told this before. He is an excellent provider. He has made me feel confident about my treatment which I think has/had a tremendous amount of impact on my care and the outcome. I would recommend him and the facility in a heart beat." -Felicia
Dr. Singavi’s clinical interests include solid tumors and hematologic disorders (both malignant and non-malignant – thrombotic/bleeding disorders/etc.). His special interests include breast cancer, gastrointestinal cancers, brain tumors, and lung cancer.
When not working, Dr. Singavi enjoys spending time with his family, traveling, and watching sports.
"My father has been a patient of Dr Singavi for 3 years. Dr Singavi is an absolute gem! He is compassionate and very knowledgeable. He takes his time to listen to patient concerns and help the patient/family understand the treatment plan. I can’t say enough how grateful I am my father is in his care. It’s so rare to find a doctor that is both skilled in his field and has top notch bed side manor. Dr Singavi is both!!" -Laura
"Dr. Singavi is the most amazing Dr. He is kind, compassionate, and takes all the time in the world to make sure you understand your condition, and your treatment plan. His entire office staff is also very compassionate and carring. If you have to see an Oncologist, and let's face it, nobody wants to, Dr. Singavi and his staff are the people you want to be with during your care." -Sandy
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
/assets/docs/441981.png)
/assets/docs/441977.png){kind=small}
